Manus Bio focuses on developing sustainable bioalternatives to traditional petrochemical and agricultural products through advanced synthetic biology techniques. At the heart of their innovation is the use of engineered microbial cell factories, which are designed to produce bioalternatives efficiently and sustainably. Their proprietary BioOptimization Cycle™ allows for the rapid optimization of biocatalysts and metabolic pathways, enabling the production of a wide range of complex molecules. This approach not only enhances yield and performance but also significantly reduces the environmental impact associated with conventional manufacturing processes.

The company boasts a comprehensive scale-up platform that integrates every step from cell factory design to large-scale biomanufacturing. Their state-of-the-art BioFacilities are equipped for precision fermentation, ensuring that promising strains can be developed and brought to market effectively. Manus Bio's expertise in metabolic engineering, enzyme optimization, and systems biology allows them to create high-yield production systems tailored for commercial applications. With over 200 patents, Manus Bio is positioned as a leader in the bioalternatives space, helping companies transition to more sustainable practices while maintaining product quality and affordability.

United States

Manus is the world's leading bioalternatives scale-up platform. We work with companies across industries and value chains to accelerate the transition to bioalternatives – better performing and more sustainable versions of complex molecules traditionally sourced from plants, animals, or fossil fuels. Our platform is proven to work across scales, bridging the Valley of Death between lab and manufacturing more efficiently and more reliably to deliver the benefits of synthetic biology, today.

Manus Bio

Company Details